ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $733,000 | +14.7% | 99,213 | -0.8% | 0.33% | +14.7% |
| Q1 2016 | $639,000 | +1.6% | 100,038 | -0.7% | 0.28% | +3.6% |
| Q4 2015 | $629,000 | +7.7% | 100,698 | +0.7% | 0.28% | +8.3% |
| Q3 2015 | $584,000 | -49.9% | 99,963 | -29.0% | 0.25% | -53.1% |
| Q2 2015 | $1,165,000 | -18.2% | 140,870 | -18.5% | 0.54% | -20.6% |
| Q1 2015 | $1,424,000 | +20.2% | 172,875 | +0.2% | 0.68% | +16.8% |
| Q4 2014 | $1,185,000 | +19.9% | 172,475 | -5.7% | 0.58% | +17.2% |
| Q3 2014 | $988,000 | +4.4% | 182,975 | +23.3% | 0.50% | +6.4% |
| Q2 2014 | $946,000 | +827.5% | 148,450 | +1078.2% | 0.47% | +819.6% |
| Q1 2014 | $102,000 | – | 12,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |